MedNet.nl: Cancer patients treated with immune checkpoint inhibitors have an increased risk of major adverse cardiovascular events if they have a history of atherosclerotic cardiovascular disease or hypertension. Timely identification of this population is therefore essential.
04-09-2023 | Cancer Immunotherapy | News
ESC 2023